In this case, ADAR1 has been proposed to edit mismatched hybrids formed by TERRAs and non-canonical telomeric repeats in order to facilitate its removal by RNaseH2, a phenomenon that is specific in non-ALT cancer cell lines. This evidence concerns the gene ADAR and cancer.